Some European conservatives cultivated a relationship with Russia over the years, not necessarily because they loved the country, but because they saw it as a potential hedge against a dominant liberal Brussels.
After New York state’s top court this week crushed Democratic hopes of coming out ahead in this decade’s redistricting cycle, the party faces an increasingly precarious legal environment in the hyper-partisan battle over drawing legislative lines.
The U.S. Food and Drug Administration (FDA) on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants four weeks and older.
After confirmation that Elon Musk had bought Twitter in a $44 billion deal, founder Jack Dorsey praised the entrepreneur for “taking it back from Wall Street”.
The very concept of Public Health, once a rather innocuous term, is facing an extinction level event, and Americans should be incredibly thankful for this development.
Democrats have much more to worry about than losing the House, and possibly the Senate: the possibility of a re-elected President Trump with a compliant, veto-proof Senate majority in January 2025.
